Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Bryan

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 4, 2020
Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis ProgrammeMitch van Hensbergen, Frits H M van Osch, Sylvia Jochems, et al.
Nature Reviews. Cancer|September 25, 2025
Unlocking the potential of urine-based liquid biopsy through improved reporting and standardizationDouglas G Ward, Richard T Bryan, Aadel A Chaudhuri, et al.
European Urology|March 24, 2025
Towards Epigenetic-based Subtyping of Bladder Cancer: DNA Methylation Predicts Molecular Subtypes of Non-muscle-invasive Bladder CancerMinghao Yu, Anshita Goel, Benjamin Tura, et al.
European Urology Oncology|July 7, 2019
Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non-muscle-invasive Bladder CancerNadezda Lipunova, Anke Wesselius, Kar K Cheng, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCTNicholas James, Sarah Pirrie, Wenyu Liu, et al.
Biochemistry and Biophysics Reports|May 1, 2026
The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomesAzad K Saeed, Panagiotis Triantafyllakis, Naheema S Gordon, et al.
Plos One|September 21, 2017
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancerAlexander C Dowell, Ellen Cobby, Kaisheng Wen, et al.
Scientific Reports|July 28, 2018
Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumoursMatthew A Llewellyn, Naheema S Gordon, Ben Abbotts, et al.
Oncotarget|June 5, 2018
Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratificationKym I E Snell, Douglas G Ward, Naheema S Gordon, et al.
Scandinavian Journal of Urology|November 15, 2021
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancerBeth Russell, Fredrik Liedberg, Oskar Hagberg, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 4, 2020
Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis ProgrammeMitch van Hensbergen, Frits H M van Osch, Sylvia Jochems, et al.
Nature Reviews. Cancer|September 25, 2025
Unlocking the potential of urine-based liquid biopsy through improved reporting and standardizationDouglas G Ward, Richard T Bryan, Aadel A Chaudhuri, et al.
European Urology|March 24, 2025
Towards Epigenetic-based Subtyping of Bladder Cancer: DNA Methylation Predicts Molecular Subtypes of Non-muscle-invasive Bladder CancerMinghao Yu, Anshita Goel, Benjamin Tura, et al.
European Urology Oncology|July 7, 2019
Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non-muscle-invasive Bladder CancerNadezda Lipunova, Anke Wesselius, Kar K Cheng, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCTNicholas James, Sarah Pirrie, Wenyu Liu, et al.
Biochemistry and Biophysics Reports|May 1, 2026
The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomesAzad K Saeed, Panagiotis Triantafyllakis, Naheema S Gordon, et al.
Plos One|September 21, 2017
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancerAlexander C Dowell, Ellen Cobby, Kaisheng Wen, et al.
Scientific Reports|July 28, 2018
Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumoursMatthew A Llewellyn, Naheema S Gordon, Ben Abbotts, et al.
Oncotarget|June 5, 2018
Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratificationKym I E Snell, Douglas G Ward, Naheema S Gordon, et al.
Scandinavian Journal of Urology|November 15, 2021
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancerBeth Russell, Fredrik Liedberg, Oskar Hagberg, et al.
Pageof 14